Clinical Trial

A Two-arm, Open-label, Single-sequence, Multiple-dose, Cross-over Study to Evaluate the Pharmacokinetic Interaction and the Safety of UIC202502 and UIC202505 in Healthy Adult Volunteers

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated September 9, 2025 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study is open-label, multiple-dose, two-intervention group, single-sequence, crossover design to compare the safety and pharmacokinetics of UIC202502 and UIC202505 when administered alone or in combination.
Trial Details
NCT Number NCT07162441
Lead Sponsor Korea United Pharm. Inc.
Conditions Dyslipidemia
Enrollment 50 participants
Start Date 2025-08-12
Primary Completion 2025-09-30 (estimated)
Study Completion 2026-03-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-09